Market Cap 28.94M
Revenue (ttm) 37.04M
Net Income (ttm) 12.45M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 33.62%
Debt to Equity Ratio 0.00
Volume 188,100
Avg Vol 129,708
Day's Range N/A - N/A
Shares Out 26.55M
Stochastic %K 28%
Beta -1.06
Analysts Strong Buy
Price Target N/A

Company Profile

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as soft tissue ablation...

Industry: Medical Devices
Sector: Healthcare
Phone: 86 20 8218 5926
Address:
Baide Building, Building 11, Room 202, 2/F No.15 Rongtong Street, Yuexiu District, Guangzhou, China
Stockboy1234567
Stockboy1234567 Jan. 28 at 11:53 PM
$BDMD going up
0 · Reply
Torete8
Torete8 Jan. 27 at 7:21 PM
$BDMD buyyyyyyy
0 · Reply
Dou_said_it
Dou_said_it Jan. 27 at 4:13 PM
$BDMD i saw 1.22$ before opening… hope this will go up
0 · Reply
ZorroKing
ZorroKing Jan. 26 at 2:13 PM
$BDMD https://finance.yahoo.com/news/baird-medical-accelerates-global-commercial-133000091.html 🫢 🚀
0 · Reply
Sudhakar1990
Sudhakar1990 Jan. 23 at 7:09 PM
$BDMD 📈👀📉
1 · Reply
Stockboy1234567
Stockboy1234567 Jan. 21 at 3:47 AM
$BDMD I thought the following was insightful! The F-1 registration statement filed in late 2024 registers approximately 33.8 million shares for resale by selling securityholders, representing ~71% of the outstanding shares. This creates a "supply wall." Every time the stock rallies, these legacy holders (Betters Medical and SPAC sponsors) have the option to sell. However, it is crucial to note that Betters Medical is the entity controlled by the founder, Ms. Haimei Wu. It is highly improbable that the founder would liquidate her controlling stake at near-record lows ($1.20), as this would destroy her own equity value. The "perceived" overhang is likely greater than the "actual" overhang, creating a pricing inefficiency that value investors can exploit.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 20 at 6:45 PM
$BDMD Excellent article that nails exactly where BDMD stands right now. So if you want to update your BDMD knowledge or get acquainted with BDMD, this is a must read. https://everyticker.com/quote/BDMD/analysis/bdmd-s-china-mwa-dominance-meets-a-liquidity-crunch-a-thyroid-leader-s-path-to-global-scale-or-delisting-risk
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 20 at 6:37 AM
$BDMD Brilliant piece that captures BDMD's situation perfectly. So if you want to update your understanding of BDMD or get to know BDMD better, this is essential reading. https://everyticker.com/quote/BDMD/analysis/bdmd-s-china-mwa-dominance-meets-a-liquidity-crunch-a-thyroid-leader-s-path-to-global-scale-or-delisting-risk
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 19 at 5:13 PM
$BDMD RSI: 20.93, MACD: -0.0494 Vol: 0.07, MA20: 1.34, MA50: 1.36 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Sudhakar1990
Sudhakar1990 Jan. 15 at 5:23 PM
$BDMD My point of view: best entry point $1.10 - $1.15.
0 · Reply
Latest News on BDMD
Baird Medical Engages Global Clinical Leaders at AAES 2025

May 19, 2025, 8:30 AM EDT - 9 months ago

Baird Medical Engages Global Clinical Leaders at AAES 2025


Baird Medical to Participate in the AAES 2025 Annual Meeting

May 6, 2025, 8:30 AM EDT - 9 months ago

Baird Medical to Participate in the AAES 2025 Annual Meeting


Baird Medical to Participate in COSM 2025 Conference

May 5, 2025, 8:30 AM EDT - 9 months ago

Baird Medical to Participate in COSM 2025 Conference


Baird Medical to Participate in NASIT 2025 Conference

Jan 24, 2025, 8:30 AM EST - 1 year ago

Baird Medical to Participate in NASIT 2025 Conference


Baird Medical to Attend Microcap Conference at Borgata Hotel

Jan 23, 2025, 8:30 AM EST - 1 year ago

Baird Medical to Attend Microcap Conference at Borgata Hotel


Stockboy1234567
Stockboy1234567 Jan. 28 at 11:53 PM
$BDMD going up
0 · Reply
Torete8
Torete8 Jan. 27 at 7:21 PM
$BDMD buyyyyyyy
0 · Reply
Dou_said_it
Dou_said_it Jan. 27 at 4:13 PM
$BDMD i saw 1.22$ before opening… hope this will go up
0 · Reply
ZorroKing
ZorroKing Jan. 26 at 2:13 PM
$BDMD https://finance.yahoo.com/news/baird-medical-accelerates-global-commercial-133000091.html 🫢 🚀
0 · Reply
Sudhakar1990
Sudhakar1990 Jan. 23 at 7:09 PM
$BDMD 📈👀📉
1 · Reply
Stockboy1234567
Stockboy1234567 Jan. 21 at 3:47 AM
$BDMD I thought the following was insightful! The F-1 registration statement filed in late 2024 registers approximately 33.8 million shares for resale by selling securityholders, representing ~71% of the outstanding shares. This creates a "supply wall." Every time the stock rallies, these legacy holders (Betters Medical and SPAC sponsors) have the option to sell. However, it is crucial to note that Betters Medical is the entity controlled by the founder, Ms. Haimei Wu. It is highly improbable that the founder would liquidate her controlling stake at near-record lows ($1.20), as this would destroy her own equity value. The "perceived" overhang is likely greater than the "actual" overhang, creating a pricing inefficiency that value investors can exploit.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 20 at 6:45 PM
$BDMD Excellent article that nails exactly where BDMD stands right now. So if you want to update your BDMD knowledge or get acquainted with BDMD, this is a must read. https://everyticker.com/quote/BDMD/analysis/bdmd-s-china-mwa-dominance-meets-a-liquidity-crunch-a-thyroid-leader-s-path-to-global-scale-or-delisting-risk
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 20 at 6:37 AM
$BDMD Brilliant piece that captures BDMD's situation perfectly. So if you want to update your understanding of BDMD or get to know BDMD better, this is essential reading. https://everyticker.com/quote/BDMD/analysis/bdmd-s-china-mwa-dominance-meets-a-liquidity-crunch-a-thyroid-leader-s-path-to-global-scale-or-delisting-risk
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 19 at 5:13 PM
$BDMD RSI: 20.93, MACD: -0.0494 Vol: 0.07, MA20: 1.34, MA50: 1.36 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Sudhakar1990
Sudhakar1990 Jan. 15 at 5:23 PM
$BDMD My point of view: best entry point $1.10 - $1.15.
0 · Reply
Stockboy1234567
Stockboy1234567 Jan. 15 at 5:03 PM
$BDMD I think we have yet to see the impact of the expansion into Vietnam and Pakistan and the cost to borrow is extremely high as well.
0 · Reply
neeradampeter
neeradampeter Jan. 15 at 2:09 PM
$BDMD Indeed, $1.29 is a good entry point right now — the project is very promising!
0 · Reply
Stockboy1234567
Stockboy1234567 Jan. 8 at 4:02 PM
$BDMD I think this will go up in the short term.
1 · Reply
Sudhakar1990
Sudhakar1990 Jan. 7 at 10:30 PM
0 · Reply
Silverstripe
Silverstripe Dec. 31 at 12:34 PM
$BDMD let new year blast begin like year before?
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 30 at 8:54 PM
$BDMD Current Stock Price: $1.37
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 30 at 8:23 PM
0 · Reply
ReserveRatioR
ReserveRatioR Dec. 27 at 9:51 AM
$BDMD The backdrop favors measured delivery over aggressive expansion promises. Balance‑sheet flexibility may prove significant. Evidence of repeatability could meaningfully alter perception. Compounding requires operational consistency.
0 · Reply
ConquestCaptain
ConquestCaptain Dec. 26 at 8:49 AM
$BDMD Sentiment here is shifting toward proof-driven evaluation rather than narrative enthusiasm. Efficiency gains must pair with selective investment. Missed steps could quickly reignite skepticism. Patience is sensible — but only if matched by progress.
0 · Reply
Investor6
Investor6 Dec. 23 at 10:31 AM
$BDMD 's Microwave Ablation (MWA) is a recent, minimally invasive cancer treatment using electromagnetic waves (microwaves) to heat and destroy cancerous tumors, creating a large, fast-growing zone of dead tissue through frictional heating of water molecules, making it effective for liver, lung, kidney, and bone tumors, often as an alternative for non-surgical patients or when other methods like RFA fall short. MWA offers benefits like faster treatment, larger ablation zones, and potential immune activation, but requires advanced antennas and cooling to manage heat effectively, especially in delicate areas. This is the reason Baird Medical as a leader on this technology expands its presentence is new markets like U.S., Egypt, Malaysia, Bangladesh, etc. Baird Medical holds several patents, mainly for its MWA technology. The company was the first in China to get Class III MWA device approval for thyroid nodules. More about MWA: https://www.sciencedirect.com/science/article/pii/S2589004225004365
0 · Reply
JoMomentum
JoMomentum Dec. 22 at 8:31 AM
0 · Reply
OGUZATA
OGUZATA Dec. 18 at 8:19 PM
$BDMD in from 1.40 🤝
0 · Reply